» Authors » Daniel Rembao

Daniel Rembao

Explore the profile of Daniel Rembao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 161
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vazquez Cervantes G, Pineda B, Ramirez Ortega D, Salazar A, Gonzalez Esquivel D, Rembao D, et al.
Cells . 2021 Aug; 10(8). PMID: 34440798
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor. The enzyme indoleamine-2,3-dioxygenase (IDO), which participates in the rate-limiting step of tryptophan catabolism through the kynurenine pathway (KP),...
2.
Serratos I, Castellanos P, Pastor N, Millan-Pacheco C, Colin-Gonzalez A, Rembao D, et al.
Chem Biol Interact . 2016 Feb; 249:10-8. PMID: 26902637
The receptor for advanced glycation end products (RAGE) is commonly involved in different neurodegenerative and inflammatory disorders. The cellular signaling associated to RAGE activation may occur upon binding to different...
3.
Ochoa-Ruiz E, Diaz-Ruiz R, Hernandez-Vazquez A, Ibarra-Gonzalez I, Ortiz-Plata A, Rembao D, et al.
Mol Genet Metab . 2015 Sep; 116(3):204-14. PMID: 26343941
Certain inborn errors of metabolism result from deficiencies in biotin containing enzymes. These disorders are mimicked by dietary absence or insufficiency of biotin, ATP deficit being a major effect,whose responsible...
4.
Serratos I, Castellanos P, Pastor N, Millan-Pacheco C, Rembao D, Perez-Montfort R, et al.
PLoS One . 2015 Mar; 10(3):e0120221. PMID: 25757085
The receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor involved in neurodegenerative and inflammatory disorders. RAGE induces cellular signaling upon binding to a variety of ligands. Evidence...
5.
Hernandez-Abreu O, Torres-Piedra M, Garcia-Jimenez S, Ibarra-Barajas M, Villalobos-Molina R, Montes S, et al.
J Ethnopharmacol . 2013 Jan; 146(1):187-91. PMID: 23276782
Ethnopharmacological Relevance: Agastache mexicana is used in Mexican traditional medicine for the treatment of hypertension, anxiety and related diseases. Aim Of The Study: Current work was developed to establish pharmacological/toxicological...
6.
Hernandez Pando R, Aguilar D, Cohen I, Guerrero M, Ribon W, Acosta P, et al.
Tuberculosis (Edinb) . 2010 Jun; 90(4):268-77. PMID: 20580613
Meningeal tuberculosis is a severe type of extrapulmonary disease, which is thought to begin with respiratory infection, followed by hematogenous dissemination and brain infection. Host genetic susceptibility factors and specific...
7.
Tena-Suck M, Moreno-Reyes I, Rembao D, Vega R, Moreno-Jimenez S, de Jesus Castillejos-Lopez M, et al.
Gac Med Mex . 2010 Jan; 145(5):361-8. PMID: 20073441
Background: Craniopharyngioma is a sellar region benign cyst It's frequency ranges from 1.2% to 4.6% of all brain tumors. Objective: To carry out a clinical pathological correlation of craniopharyngioma among...
8.
Guevara P, Escobar-Arriaga E, Saavedra-Perez D, Martinez-Rumayor A, Flores-Estrada D, Rembao D, et al.
J Neurooncol . 2009 Dec; 98(3):379-84. PMID: 20013146
Meningiomas are benign tumors, with low rate of recurrence after surgery. The most important factor predicting recurrence is the extent of surgical resection; other factors have been studied with conflicting...
9.
Garcia-Navarro V, Tena-Suck M, Celis M, Vega R, Rembao D, Salinas C
Arq Neuropsiquiatr . 2009 Sep; 67(3A):707-9. PMID: 19722057
No abstract available.
10.
Mandujano A, Montes S, Guzman A, Espinosa B, Rembao D, Martinez-Cairo S, et al.
Gac Med Mex . 2006 Nov; 142(5):399-406. PMID: 17128820
Prion diseases are a group of degenerative disorders characterized by being progressive, fast growing, and fatal, they affect humans and animals. Due to their physiopathogeny, these disorders can be sporadic,...